🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
17,82 USD
Máx. histórico
178,74
2145 días
Split 1:6 del 12/07/2012
Caída desde máximo
-90,03%
Rango 52 semanas
14,68 – 24,68
Variación hoy
+1,42%
Cierre anterior
17,57
Rango de hoy
17,52 – 18,77
Volumen hoy
2.596.193
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,43%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 19 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/01/2012 | 4,86 | 5,46 | 4,86 | 5,16 | +4,88% | 12,35% | 72.367 |
| 20/01/2012 | 5,16 | 5,22 | 4,80 | 4,92 | -4,65% | 8,14% | 78.133 |
| 19/01/2012 | 5,34 | 5,40 | 5,10 | 5,16 | -3,37% | 5,62% | 43.833 |
| 18/01/2012 | 5,28 | 5,52 | 5,10 | 5,34 | +1,14% | 7,95% | 71.717 |
| 17/01/2012 | 5,70 | 5,94 | 5,22 | 5,28 | -6,38% | 12,63% | 105.900 |
| 13/01/2012 | 5,10 | 5,70 | 5,10 | 5,64 | +3,30% | 11,76% | 84.217 |
| 12/01/2012 | 5,70 | 5,70 | 5,16 | 5,46 | -2,15% | 9,47% | 67.100 |
| 11/01/2012 | 5,52 | 5,58 | 5,10 | 5,58 | +1,09% | 8,70% | 122.067 |
| 10/01/2012 | 5,28 | 5,82 | 5,22 | 5,52 | +5,75% | 11,36% | 140.550 |
| 09/01/2012 | 5,22 | 5,46 | 4,92 | 5,22 | +6,10% | 10,34% | 158.517 |
| 06/01/2012 | 4,56 | 5,22 | 4,50 | 4,92 | +7,89% | 15,79% | 205.750 |
| 05/01/2012 | 4,56 | 4,62 | 4,26 | 4,56 | +1,33% | 7,89% | 72.317 |
| 04/01/2012 | 4,50 | 4,56 | 4,38 | 4,50 | +1,35% | 4,00% | 64.733 |
| 03/01/2012 | 4,56 | 4,56 | 4,20 | 4,44 | -1,33% | 7,89% | 110.800 |
| 30/12/2011 | 4,50 | 4,56 | 4,20 | 4,50 | -1,32% | 8,00% | 114.017 |
| 29/12/2011 | 4,32 | 4,62 | 4,14 | 4,56 | +7,04% | 11,11% | 183.433 |
| 28/12/2011 | 4,44 | 4,62 | 4,26 | 4,26 | -5,33% | 8,11% | 103.033 |
| 27/12/2011 | 4,68 | 4,86 | 4,32 | 4,50 | -2,60% | 11,54% | 121.900 |
| 23/12/2011 | 4,74 | 4,98 | 4,50 | 4,62 | +0,00% | 10,13% | 112.583 |
| 22/12/2011 | 4,50 | 4,92 | 4,26 | 4,62 | +4,05% | 14,67% | 171.583 |
| 21/12/2011 | 3,60 | 4,50 | 3,60 | 4,44 | +23,33% | 25,00% | 171.467 |
| 20/12/2011 | 3,36 | 3,78 | 3,30 | 3,60 | +11,11% | 14,29% | 166.183 |
| 19/12/2011 | 3,30 | 3,54 | 3,24 | 3,24 | -3,57% | 9,09% | 121.000 |
| 16/12/2011 | 3,30 | 3,66 | 3,24 | 3,36 | +1,82% | 12,73% | 311.983 |
| 15/12/2011 | 3,42 | 3,60 | 3,00 | 3,30 | -3,51% | 17,54% | 343.767 |
| 14/12/2011 | 3,78 | 3,78 | 3,30 | 3,42 | -13,64% | 12,70% | 329.750 |
| 13/12/2011 | 4,44 | 4,68 | 3,96 | 3,96 | -9,59% | 16,22% | 138.017 |
| 12/12/2011 | 4,14 | 4,44 | 4,14 | 4,38 | +2,82% | 7,25% | 102.283 |
| 09/12/2011 | 4,08 | 4,32 | 4,08 | 4,26 | +4,41% | 5,88% | 65.600 |
| 08/12/2011 | 4,20 | 4,32 | 4,02 | 4,08 | -2,86% | 7,14% | 74.150 |